Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$19,800,000
Company Info
- Founders
- Michal Mashiach
- Company Description
- A biotech company building a platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health. EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.
- Market
- Healthcare & Wellness
- Coinvestors
- Tal Ventures,Reinforced Ventures,NFX
Links